Is LGG Safe for Newborns and Infants?

Lactobacillus rhamnosus GG has a strong safety record in healthy term newborns and infants, with adverse effects in clinical trials occurring at similar rates to placebo. Rare bloodstream infections have been reported, almost entirely in babies with serious underlying vulnerabilities. For a healthy term infant, the main safety steps are choosing a verified product and following medical advice.

What do clinical trials show about LGG safety?

Randomised trials of LGG in infants and children have collectively enrolled many thousands of participants. Across these trials, rates of side effects such as vomiting, rash and abdominal discomfort were generally no different between LGG and placebo groups.

Long-term follow-up adds reassurance. In the Finnish eczema prevention trial, infants given LGG from birth were followed for several years, with no signal of harm in growth or general health.

Population data provide another check, because rare harms can escape detection in trials of a few hundred children. LGG has been widely consumed in Finland since the 1990s through dairy products. A national surveillance study found that the rate of Lactobacillus bloodstream infections did not rise as LGG consumption increased.

How often does LGG cause infection?

Infection caused by LGG is rare. When it does occur, it is usually bacteraemia, meaning bacteria present in the bloodstream, and it has been documented mainly in:

• critically ill children in intensive care
• infants with short bowel syndrome after gut surgery
• patients with central venous catheters
• people with severely weakened immune systems
• preterm infants receiving neonatal care

In several reported cases, genetic sequencing confirmed that the bacteria in the blood matched the strain in the probiotic product. This proves the probiotic can occasionally cross into the bloodstream when the gut barrier or immune defences are compromised. It does not indicate a risk for healthy infants.

Does LGG carry antibiotic resistance genes?

LGG is naturally resistant to vancomycin, an antibiotic used for serious infections. This resistance comes from the structure of its cell wall and is encoded on the chromosome, not on mobile genetic elements such as plasmids that bacteria can pass to each other. Current evidence indicates it does not spread vancomycin resistance to other bacteria.

This property matters in the rare event of LGG bloodstream infection. Doctors need to know the child has taken LGG, because vancomycin would not treat it. Other antibiotics, such as ampicillin, are usually effective, and blood culture laboratories can identify the organism and test its sensitivities within a few days. Any parent whose child is admitted to hospital should mention probiotic use.

Why does product quality matter for infant safety?

A safe strain can still reach a baby in an unsafe product if manufacturing standards are poor. Contamination of probiotic products with other microbes, including moulds, has been reported internationally. Quality markers parents can check include:

• the full strain code, ATCC 53103 for LGG
• a CFU count guaranteed until expiry
• manufacture in a GMP Certified facility
• an intact seal and clear storage instructions

Rhambac® GG Drops from ELMED Life Sciences contain LGG ATCC 53103 at 1 billion CFU per 6 drops, with a 24-month shelf life.

Which infants need medical advice first?

Healthy term infants can receive LGG on a paediatrician's advice. Babies who should not start any probiotic without specialist direction include those born preterm or with low birth weight, those with immune deficiencies, those with central lines or recent gut surgery, babies with congenital heart disease, and any infant who is currently unwell or in hospital. Neonatal units follow separate protocols, explained in probiotics and preterm babies.

What side effects might a healthy infant show?

In healthy infants, the most commonly noticed effects are mild and temporary, such as extra wind or a change in stool consistency during the first days. Stop the drops and contact the paediatrician if the baby develops fever, persistent vomiting, rash, blood in the stool, poor feeding or unusual drowsiness. Fever of 38°C or more in a baby under three months always needs urgent assessment. Broader evidence on LGG in children is covered in LGG probiotic drops for infants and children.